Results 51 to 60 of about 2,293 (194)

Häufigkeit und diagnostische Befunde von Typ‐I‐ und Typ‐IV‐Reaktionen gegen Beta‐Laktam‐Antibiotika – Bedeutung des Zeitintervalls zwischen klinischer Reaktion und Hauttestung

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 10, Page 1383-1391, October 2024.
Zusammenfassung Hintergrund Die Prävalenz von Allergien gegen Beta‐Laktam‐Antibiotika wird aufgrund anamnestischer Daten deutlich überschätzt – mit bedeutenden medizinischen und wirtschaftlichen Folgen. Ziel der Arbeit war, die Häufigkeit von Sofort‐ und Spättypreaktionen gegenüber Beta‐Laktam‐Antibiotika zu bestimmen, um Diagnostik und Therapie zu ...
Kimberley Farmer, Elsbeth Oestmann, Margitta Worm   +2 more
wiley   +1 more source

RETRACTED: Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease

Equine Veterinary Journal, Volume 56, Issue 5, Page 952-958, September 2024.
Abstract Background Oral omeprazole is the accepted treatment for equine squamous gastric disease (ESGD); however, it is not universally effective. Esomeprazole results in more consistent and pronounced acid suppression in men and is more effective than omeprazole in the treatment of oesophageal and gastric disease.
Tania Sundra, Sarah Gough, Gabriele Rossi, Erin Kelty, David Rendle   +4 more
wiley   +1 more source

Prescripcion omeprazol IV en pacientes hospitalizados en medicina interna Hospital Cayetano Heredia, julio - diciembre 2014 [PDF]

, 2018
La presente tesis desarrolla el tema de la Prescripción omeprazol IV en pacientes hospitalizados en Medicina Interna, hospital Cayetano Heredia, Julio-Diciembre 2014" Objetivo: Determinar si la prescripción de omeprazol IV es correcta en los pacientes ...
Santos Alburqueque, Sandra Carolina
core  

Avaliação do uso profilático de omeprazol em pacientes internados no hospital estadual Américo Brasiliense

, 2015
Introduction. Omeprazole is a widely used drug; in most cases, it is effective and safe. However, studies have found omeprazole to be the drug most frequently related to hospital admissions due to adverse drug reactions (ADRs).
Abjaude, Samir Antonio Rodrigues [UNESP]
core   +2 more sources

Pericapsular Nervous Group Block versus Suprainguinal Fascia Iliaca Block Using the Same Injection Volume in Primary HIP Arthroplasty Prospective Observational Study

International Journal of Clinical Practice, Volume 2024, Issue 1, 2024.
Objectives. To determine the pericapsular nerve group (PENG) block’s postoperative analgesic efficacy and safety compared to the suprainguinal fascia iliaca (SFI) block in patients undergoing primary hip arthroplasty using the same injectate volume. Material and Methods.
Luis Baeza Álvarez, José Manuel López González, Gustavo Illodo Miramontes, Bárbara María Jiménez Gómez, María Vega Colon, Alejandra Williams Aguirre, Pablo Casas Reza, Servando López Álvarez, Shu-Wei Liao, Bing-Ying Ho, Meng-Ta Yang, Jin-De Hou, Chih-Chung Liu, I-Chi Wu, Jui-An Lin, Felice Galluccio, Okan Aslantürk   +16 more
wiley   +1 more source

Hipomagnesemia secundária ao uso crônico de Inibidores de Bomba de Prótons: Relato de Caso

Medicina, 2015
Modelo do Estudo: Relato de Caso. Objetivos: Apresentar um caso de hipomagnesemia sintomática associada a hipocalcemia induzido pelo uso de Omeprazol por cerca de 6 anos, com respectiva revisão de literatura.
Renan F. F. Nunes, Marcos A. Souza, Wogelsanger O. Pereira, Lelyanne R. P. Torquato, Felipe L. Guedes   +4 more
doaj   +1 more source

Therapeutic usage of omeprazole and corticoid in a dog with hydrocephalus unresponsive to conventional therapy
Uso terapêutico da associação do omeprazol com corticóide em um cão com hidrocefalia não-responsiva ao tratamento convencional

Semina: Ciências Agrárias, 2013
Medical therapy for hydrocephalus includes the administration of medications to limit the production of the cerebrospinal fluid (CSF) resulting in reduced intracranial pressure (ICP). This report describes the clinical findings in one dog with congenital
Alexandre Mendes Amude, Rosana Zanatta, Raquel de Souza Lemos, Lidiane Pelegrini, Fernanda Viccini, Amauri Alcindo Alfieri   +5 more
doaj   +1 more source

Omeprazol, ¿el opresor gástrico?

, 2015
Los protectores gástricos más prescritos son los IBP, en concreto el omeprazol, desbancando a los AntiH2 (protectores gástricos de primera línea en el año 2000).Los IBP han demostrado ser efectivos para las indicaciones aprobadas por la FDA recogidas en ...
Gordillo García, Alba
core  

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Efecto del consumo crónico de omeprazol en el desarrollo de anemia megaloblástica

Introducción. El omeprazol es un fármaco utilizado para combatir la enfermedad ácido-péptica, sin embargo, su uso inhibe la producción de factor intrínseco, que participa en la absorción de vitamina B12 en el intestino, cuya ausencia en el cuerpo ...
García-Montalvo, Eliud Alfredo, Verján-Andrade, Dianely, Cerna Cortés, Joel, López Alcaraz, Fátima, Valdez, Fernanda Edith   +4 more
core   +1 more source